Research & Development

Grid Item Thumb
Spectrum Pharmaceuticals announces agreement with FDA on the Special Protocol Assessment (SPA) Read more
European Medicines Agency Grants Accelerated Assessment of Ixazomib for Patients with Relapsed/Refractory Multiple Myeloma Read more
A new study published in the journal Plastic and Reconstructive Surgery proves that more breast cancer patients can qualify for Read more
Two top researchers into Alzheimer's disease receive the 2015 MetLife Foundation Awards for Medical Research Read more
The Committee for Medicinal Products for Human Use has recommended Levemir' is offered to children as young as one year Read more
A new report by Boston Healthcare has analysed the limitations of FDA approval with regards to cancer drugs Read more
A recent study in STEM CELLS Translational Medicine could open the door to a new therapy Read more
Several factors have a direct influence on adherence. Read more
Theranos has received much praise along with a healthy dose of skepticism in recent months Read more
Company reveals outcome of Topline Phase 3 Clinical Trial for Single-Dose DALVANCE' (dalbavancin) in the Treatment of ABSSSI Read more
Merrimack Pharmaceuticals, Inc. has announced updated clinical data from a multi-arm Phase 1 study of MM-141, a bispecific antibody targeting Read more
In the first study of its kind, researchers have demonstrated novel and previously unknown mechanisms of action Read more